SAN FRANCISCO--(BUSINESS WIRE)--iSchemaView, the worldwide leader in advanced imaging for stroke, today launched the newest addition to the RAPID platform, RAPID ICH1 at the 2019 Congress of Neurological Surgeons (CNS) Annual Meeting. This fully-automated system uses the latest in artificial intelligence to quickly triage non-contrast CT (NCCT) cases and notify clinicians of possible intracranial hemorrhage (ICH). RAPID ICH will enable hospitals and mobile stroke units on the front lines of stroke patient assessment to better streamline treatment decision making. For a demonstration, visit RAPID at CNS Booth #229.
Spontaneous intracranial hemorrhage accounts for 10-15% of stroke, but is one of the most disabling forms. iSchemaView/RAPID has launched RAPID ICH, a breakthrough AI-powered
RAPID ICH can detect all types of brain hemorrhages with a sensitivity and specificity greater than 90%. This innovative technology was developed and validated using over a thousand CT scans from stroke centers worldwide. This new RAPID module automatically processes images from a scanner and assesses them for hemorrhage. Results are immediately available to doctors via PACS/Workstation, RAPID Mobile app and email.
At RSNA 2019, Dunlee is announcing a new product development project to design CT replacement tubes for the next generation of GE CT scanners. The project promises to create an even broader portfolio of Dunlee CT replacement tubes. Read more>>>
“RAPID ICH is the next step in AI-powered imaging technology,” said Dr. Greg Albers, Professor of Neurology at Stanford University, Director of the Stanford Stroke Center and cofounder of iSchemaView. “By providing radiologists, neurologists and other clinicians this level of detection for all types of hemorrhages in such a small window of time, from minutes compared to the current standard of care of more than an hour, will promote better and faster decision making for improved patient care and outcomes. RAPID ICH will be extremely useful to facilitate triage decisions in both primary stroke centers and mobile stroke units.”
Developed by leading stroke experts, RAPID technology has been selected for use in several ground-breaking trials that have changed treatment guidelines issued by both the American Heart Association and American Stroke Association. The RAPID Artificial Intelligence framework combines deep learning, machine learning and expert feature extraction. It is the only clinically validated imaging solution for stroke diagnostic support worldwide. This proven platform is being used for more than 350,000 scans per year by thousands of healthcare professionals in over 40 countries.
The Complete RAPID Platform now includes: